tradingkey.logo

STAAR Surgical Co

STAA

18.490USD

+0.730+4.11%
Cierre 08/04, 16:00ETCotizaciones retrasadas 15 min
915.68MCap. mercado
PérdidaP/E TTM

STAAR Surgical Co

18.490

+0.730+4.11%
Más Datos de STAAR Surgical Co Compañía
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.
Información de la empresa
Símbolo de cotizaciónSTAA
Nombre de la empresaSTAAR Surgical Co
Fecha de salida a bolsaFeb 24, 1992
Director ejecutivoMr. Stephen C. (Steve) Farrell, CPA
Número de empleados1157
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 24
Dirección1911 Walker Ave
CiudadMONROVIA
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal91016
Teléfono16263037902
Sitio Webhttps://www.staar.com/
Símbolo de cotizaciónSTAA
Fecha de salida a bolsaFeb 24, 1992
Director ejecutivoMr. Stephen C. (Steve) Farrell, CPA
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
19.31K
+54.07%
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
10.80K
-57.51%
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
9.76K
-14.65%
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
4.60K
+27.61%
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
475.00
--
Ms. Lilian Zhou
Ms. Lilian Zhou
Independent Director
Independent Director
--
--
Mr. Brian Moore
Mr. Brian Moore
Vice President - Investor Relations and Corporate Development
Vice President - Investor Relations and Corporate Development
--
--
Mr. Arthur Crosswell Butcher
Mr. Arthur Crosswell Butcher
Independent Director
Independent Director
--
--
Dr. Elizabeth Yeu, M.D.
Dr. Elizabeth Yeu, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
19.31K
+54.07%
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
10.80K
-57.51%
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
9.76K
-14.65%
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
4.60K
+27.61%
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
475.00
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
ICLs
41.50M
97.44%
Other surgical products
1.09M
2.56%
Por regiónUSD
Nombre
Ganancia
Proporción
Others
18.02M
42.30%
Japan
11.39M
26.75%
South Korea
7.33M
17.22%
U. S.
5.46M
12.82%
China
389.00K
0.91%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
ICLs
41.50M
97.44%
Other surgical products
1.09M
2.56%
Estadísticas de accionistas
Actualizado: dom., 15 de jun
Actualizado: dom., 15 de jun
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Broadwood Capital, Inc.
27.35%
BlackRock Institutional Trust Company, N.A.
14.16%
The Vanguard Group, Inc.
8.87%
Armistice Capital LLC
6.06%
Soleus Capital Management, L.P.
5.17%
Other
38.39%
Accionistas
Accionistas
Proporción
Broadwood Capital, Inc.
27.35%
BlackRock Institutional Trust Company, N.A.
14.16%
The Vanguard Group, Inc.
8.87%
Armistice Capital LLC
6.06%
Soleus Capital Management, L.P.
5.17%
Other
38.39%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
45.54%
Investment Advisor
39.69%
Investment Advisor/Hedge Fund
15.50%
Research Firm
4.34%
Pension Fund
1.05%
Sovereign Wealth Fund
0.92%
Individual Investor
0.51%
Bank and Trust
0.35%
Venture Capital
0.06%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
542
53.50M
108.02%
-4.10M
2025Q1
586
53.67M
108.47%
-5.73M
2024Q4
611
49.68M
100.75%
-8.34M
2024Q3
633
50.35M
102.36%
-6.37M
2024Q2
636
49.69M
101.15%
-10.70M
2024Q1
632
50.54M
103.45%
-9.24M
2023Q4
640
52.70M
107.96%
-9.84M
2023Q3
658
55.47M
114.38%
-3.16M
2023Q2
667
52.64M
108.92%
-2.50M
2023Q1
670
50.91M
105.54%
-1.16M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Broadwood Capital, Inc.
13.55M
27.35%
+1.09M
+8.75%
Apr 22, 2025
BlackRock Institutional Trust Company, N.A.
7.01M
14.16%
-305.44K
-4.17%
Mar 31, 2025
The Vanguard Group, Inc.
5.41M
10.92%
-439.86K
-7.52%
Mar 31, 2025
Armistice Capital LLC
3.00M
6.06%
+2.13M
+244.04%
Mar 31, 2025
Soleus Capital Management, L.P.
2.56M
5.17%
+2.56M
--
Mar 31, 2025
Resona Asset Management Co., Ltd.
2.17M
4.38%
+669.43K
+44.62%
Mar 31, 2025
State Street Global Advisors (US)
1.99M
4.03%
-57.87K
-2.82%
Mar 31, 2025
Yunqi Capital Limited
1.94M
3.91%
+1.17M
+152.48%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.19M
2.4%
+14.77K
+1.26%
Mar 31, 2025
American Capital Management, Inc.
1.01M
2.04%
+161.75K
+19.06%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
SPDR S&P Health Care Equipment ETF
1.75%
ROBO Global Healthcare Technology & Innovation ETF
1.63%
Invesco S&P SmallCap Health Care ETF
0.59%
Royce Quant Small-Cap Quality Value ETF
0.2%
WisdomTree US SmallCap Quality Growth Fund
0.14%
Principal U.S. Small-Cap ETF
0.1%
SPDR S&P SmallCap 600 ESG ETF
0.09%
SPDR S&P 600 Small Cap Growth ETF
0.07%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.07%
iShares ESG Select Screened S&P Small-Cap ETF
0.07%
Ver más
SPDR S&P Health Care Equipment ETF
Proporción1.75%
ROBO Global Healthcare Technology & Innovation ETF
Proporción1.63%
Invesco S&P SmallCap Health Care ETF
Proporción0.59%
Royce Quant Small-Cap Quality Value ETF
Proporción0.2%
WisdomTree US SmallCap Quality Growth Fund
Proporción0.14%
Principal U.S. Small-Cap ETF
Proporción0.1%
SPDR S&P SmallCap 600 ESG ETF
Proporción0.09%
SPDR S&P 600 Small Cap Growth ETF
Proporción0.07%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proporción0.07%
iShares ESG Select Screened S&P Small-Cap ETF
Proporción0.07%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI